BIT:REC Revenue

Recordati Industria Chimica e Farmaceutica had revenue of 632.32M EUR in the quarter ending September 30, 2025, with 13.44% growth. This brings the company's revenue in the last twelve months to 2.55B, up 12.58% year-over-year. In the year 2024, Recordati Industria Chimica e Farmaceutica had annual revenue of 2.34B with 12.45% growth.

Revenue (ttm)

2.55B

Revenue Growth

+12.58%

P/S Ratio

3.81

Revenue / Employee

562.82K

Employees

4,583

Market Cap

9.73B

Revenue Chart

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2024	2.34B	259.23M	12.45%
Dec 31, 2023	2.08B	229.02M	12.36%
Dec 31, 2022	1.85B	273.23M	17.29%
Dec 31, 2021	1.58B	131.21M	9.06%
Dec 31, 2020	1.45B	-32.98M	-2.23%
Dec 31, 2019	Pro	Pro	Pro
Dec 31, 2018	Pro	Pro	Pro
Dec 31, 2017	Pro	Pro	Pro
Dec 31, 2016	Pro	Pro	Pro
Dec 31, 2015	Pro	Pro	Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name	Revenue
DiaSorin	1.21B
Amplifon	2.41B
EL.En.	580.41M
Philogen	84.66M
Safilo Group	998.89M
Pharmanutra	127.15M
Garofalo Health Care	483.61M
GPI S.p.A.	531.42M

Revenue Rankings

Recordati Industria Chimica e Farmaceutica News

9 days ago - Amarin Corp Q4 2025 Earnings Call Transcript - Benzinga
7 months ago - Italy's Recordati CEO sees rare disease drugs exempt from U.S. tariffs - Reuters
8 months ago - Five years after COVID, pharma shares languish in US policy limbo - Reuters
10 months ago - RECORDATI: STRONG MOMENTUM OF THE GROUP CONTINUES INTO THE FIRST QUARTER OF 2025 REVENUE +11.9%, EBITDA(1) +10.7%, ADJUSTED NET INCOME(2) +7.2% - GlobeNewsWire
5 years ago - 5 High-Quality Stocks in the Mediterranean - GuruFocus

More News